- Home
- NTRB vs VRCA Comparison
NTRB vs VRCA Comparison
Compare NTRB & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- VRCA
- Stock Information
- Founded
- NTRB 2016
- VRCA 2013
- Country
- NTRB United States
- VRCA United States
- Employees
- NTRB N/A
- VRCA N/A
- Industry
- NTRB Industrial Specialties
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- NTRB Health Care
- VRCA Health Care
- Exchange
- NTRB Nasdaq
- VRCA Nasdaq
- Market Cap
- NTRB 59.1M
- VRCA 54.0M
- IPO Year
- NTRB N/A
- VRCA 2018
- Fundamental
- Price
- NTRB $7.50
- VRCA $0.58
- Analyst Decision
- NTRB Buy
- VRCA Hold
- Analyst Count
- NTRB 1
- VRCA 5
- Target Price
- NTRB $13.00
- VRCA $6.00
- AVG Volume (30 Days)
- NTRB 82.0K
- VRCA 254.0K
- Earning Date
- NTRB 05-30-2025
- VRCA 08-13-2025
- Dividend Yield
- NTRB N/A
- VRCA N/A
- EPS Growth
- NTRB N/A
- VRCA N/A
- EPS
- NTRB N/A
- VRCA N/A
- Revenue
- NTRB $2,398,437.00
- VRCA $7,179,000.00
- Revenue This Year
- NTRB $560.75
- VRCA $171.87
- Revenue Next Year
- NTRB $588.39
- VRCA $71.38
- P/E Ratio
- NTRB N/A
- VRCA N/A
- Revenue Growth
- NTRB 18.92
- VRCA N/A
- 52 Week Low
- NTRB $3.72
- VRCA $0.38
- 52 Week High
- NTRB $11.78
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- NTRB 59.79
- VRCA 49.82
- Support Level
- NTRB $7.00
- VRCA $0.60
- Resistance Level
- NTRB $7.90
- VRCA $0.71
- Average True Range (ATR)
- NTRB 0.66
- VRCA 0.07
- MACD
- NTRB -0.01
- VRCA -0.00
- Stochastic Oscillator
- NTRB 37.45
- VRCA 43.69
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.